This document emerges from the assembly of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Acute Cardiovascular Care Association (ACVC). Both associations gathered their most prominent experts, including people who worked in the European areas most affected by COVID-19. Their aim was to modify diagnostic and therapeutic algorithms to adapt the evidence collected<a href="https://solaci.org/en/2020/07/16/european-association-of-percutaneous-cardiovascular-interventions-position-statement-during-the-pandemic/" title="Read more" >...</a>
EuroPCR 2020 | Sudden Death Increase Two to Three Times While MI Rate Falls
The number of sudden deaths reported around the world is on the rise in Covid-19 times. These deaths are caused either by the virus and its capacity to produce lethal arrhythmias or by the fact that patients are staying away from hospitals and are not being examined. Cardiologists were the first to warn that the<a href="https://solaci.org/en/2020/07/08/europcr-2020-sudden-death-increase-two-to-three-times-while-mi-rate-falls/" title="Read more" >...</a>
Thrombosis and Thromboembolism Associated with COVID-19
Coronavirus disease 2019 (COVID-19) is a viral respiratory illness that can cause a severe acute respiratory syndrome (SARS-CoV-2), predisposing patients to thrombosis (both in veins and arteries) due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. In addition, many patients receiving antithrombotic therapy for different indications may now become infected with COVID-19, which can<a href="https://solaci.org/en/2020/05/13/thrombosis-and-thromboembolism-associated-with-covid-19/" title="Read more" >...</a>
BIOFLOW V: Ultrathin Struts Confirm their Benefits
For several years we have been testing new devices that have introduce changes with respect to their predecessors in the hope they will bring clinical benefits. And so, the different generations of drug eluting stents came about (DES) even though we found ourselves stuck in the second generation, with the classical everolimus eluting stents. All<a href="https://solaci.org/en/2020/05/07/bioflow-v-ultrathin-struts-confirm-their-benefits/" title="Read more" >...</a>
The most read scientific articles on interventional cardiology in april
01- ECS Guidelines for COVID-19 Management One of the first statements in this document points out these are not “regular guidelines” developed after thorough analysis of all the available evidence published since the last update. Instead, they are meant to provide temporary basic management pointers on how to handle different scenarios of cardiac patients in the<a href="https://solaci.org/en/2020/05/06/the-most-read-scientific-articles-on-interventional-cardiology-in-april/" title="Read more" >...</a>
ECS Guidelines for COVID-19 Management
One of the first statements in this document points out these are not “regular guidelines” developed after thorough analysis of all the available evidence published since the last update. Instead, they are meant to provide temporary basic management pointers on how to handle different scenarios of cardiac patients in the context of the COVID-19 pandemic.<a href="https://solaci.org/en/2020/04/27/ecs-guidelines-for-covid-19-management/" title="Read more" >...</a>
Cardio Update Europe 2020 | 5 Registration Grants for SOLACI Members
The 6th Cardio Update Europe 2020 will take place between October 02 and 03, 2020 in the city of Prague (Czech Republic). As such, SOLACI is offering a total of 5 free tickets (on-site or online) for those SOLACI members interested in attending the event (this benefit does not include accommodation or airfare). In order<a href="https://solaci.org/en/2020/04/15/cardio-update-europe-2020-5-registration-grants-for-solaci-members/" title="Read more" >...</a>
Tricuspid valve: Is Percutaneous Intervention Feasible in Patients with Definite Pacemaker?
Courtesy of Dr. Carlos Fava. As we know, with higher life expectancy comes a significant increase in the use of definite pacemakers, defibrillators and resynchronization devices. Along these lines, the presence of catheters is associated to tricuspid regurgitation, which over time might become severe, leading to cardiac regurgitation and potentially heart failure. This group is<a href="https://solaci.org/en/2020/04/13/tricuspid-valve-is-percutaneous-intervention-feasible-in-patients-with-definite-pacemaker/" title="Read more" >...</a>
Virtual ACC 2020 | PARTNER 3: TAVR vs CABG in Low Risk at 2 Years
The 2-year outcomes in patients with severe aortic stenosis and low surgical risk continue to show a numerical benefit in favor of transcatheter aortic valve replacement (TAVR) vs. surgical replacement (CABG) for the primary end point of death, stroke or repeat hospitalization for cardiovascular reasons. However, the initially higher advantage of TAVR has been narrowing<a href="https://solaci.org/en/2020/04/02/virtual-acc-2020-partner-3-tavr-vs-cabg-in-low-risk-at-2-years/" title="Read more" >...</a>
Virtual ACC 2020 | Relationship between Ischemia Severity and CAD
The ISCHEMIA trial enables countless sub-studies. Many of them have made part of the virtual ACC 2020, and among them you will find the present study. This analysis finds it is the anatomy — rather than ischemia — which predicts events. And even more interesting is the fact that revascularizing this particular anatomy will not<a href="https://solaci.org/en/2020/04/01/virtual-acc-2020-relationship-between-ischemia-severity-and-cad/" title="Read more" >...</a>